-- Johnson & Johnson capped its Covid-19 vaccine trial volunteer count at 40,000--20,000 fewer than planned--due to the pervasiveness of the virus across the U.S., according to a report by Stat.

-- The study, which started on Sept. 23, will reach its milestone at the same rate with fewer participating volunteers as cases continue to soar in the country.

 

Full story: https://bit.ly/371DTDe

 

(END) Dow Jones Newswires

December 09, 2020 16:03 ET (21:03 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024 Plus de graphiques de la Bourse Johnson and Johnson
Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024 Plus de graphiques de la Bourse Johnson and Johnson